PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.00%
OCF growth of 0.00% while ANO.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
0.00%
FCF growth of 0.00% while ANO.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-68.82%
Negative 10Y revenue/share CAGR while ANO.AX stands at 18.71%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
2.04%
5Y revenue/share CAGR under 50% of ANO.AX's 170.65%. Michael Burry would suspect a significant competitive gap or product weakness.
23.51%
3Y revenue/share CAGR under 50% of ANO.AX's 60.20%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-134.17%
Negative 10Y OCF/share CAGR while ANO.AX stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-118.13%
Negative 5Y OCF/share CAGR while ANO.AX is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-124.87%
Negative 3Y OCF/share CAGR while ANO.AX stands at 82.40%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
177.00%
Net income/share CAGR above 1.5x ANO.AX's 116.72% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
133.44%
Below 50% of ANO.AX's 650.19%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
100.00%
Below 50% of ANO.AX's 2934.68%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
9681.11%
5Y equity/share CAGR above 1.5x ANO.AX's 46.42%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
260.24%
3Y equity/share CAGR above 1.5x ANO.AX's 16.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
29.78%
AR growth of 29.78% while ANO.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.